A network-based data integration approach to support drug repurposing and multi-Target therapies in triple negative breast cancer

Francesca Vitali, Laurie D. Cohen, Andrea Demartini, Angela Amato, Vincenzo Eterno, Alberto Zambelli, Riccardo Bellazzi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The integration of data and knowledge from heterogeneous sources can be a key success factor in drug design, drug repurposing and multi-Target therapies. In this context, biological networks provide a useful instrument to highlight the relationships and to model the phenomena underlying therapeutic action in cancer. In our work, we applied network-based modeling within a novel bioinformatics pipeline to identify promisingmulti-Target drugs. Given a certain tumor type/subtype, we derive a disease-specific Protein-Protein Interaction (PPI) network by combining different data-bases and knowledge repositories. Next, the application of suitable graph-based algorithms allows selecting a set of potentially interesting combinations of drug targets. A list of drug candidates is then extracted by applying a recent data fusion approach based on matrix tri-factorization.Available knowledge about selected drugs mechanisms of action is finally exploited to identify the most promising candidates for planning in vitro studies.We applied this approach to the case of Triple Negative Breast Cancer (TNBC), a subtype of breast cancer whose biology is poorly understood and that lacks of specific molecular targets. Our "in-silico" findings have been confirmedby a number of in vitro experiments, whose results demonstrated the ability of the method to select candidates for drug repurposing.

Original languageEnglish
Article numbere0162407
JournalPLoS One
Volume11
Issue number9
DOIs
Publication statusPublished - Sep 1 2016

Fingerprint

Drug Repositioning
Triple Negative Breast Neoplasms
Data integration
breast neoplasms
drugs
therapeutics
Pharmaceutical Preparations
Protein Interaction Maps
Drug Design
Drug Combinations
Computational Biology
Computer Simulation
Neoplasms
Therapeutics
Databases
Breast Neoplasms
combination drug therapy
neoplasms
Data fusion
protein-protein interactions

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

A network-based data integration approach to support drug repurposing and multi-Target therapies in triple negative breast cancer. / Vitali, Francesca; Cohen, Laurie D.; Demartini, Andrea; Amato, Angela; Eterno, Vincenzo; Zambelli, Alberto; Bellazzi, Riccardo.

In: PLoS One, Vol. 11, No. 9, e0162407, 01.09.2016.

Research output: Contribution to journalArticle

Vitali, Francesca ; Cohen, Laurie D. ; Demartini, Andrea ; Amato, Angela ; Eterno, Vincenzo ; Zambelli, Alberto ; Bellazzi, Riccardo. / A network-based data integration approach to support drug repurposing and multi-Target therapies in triple negative breast cancer. In: PLoS One. 2016 ; Vol. 11, No. 9.
@article{67ec7aba80494eb5a951c3fbbeff5917,
title = "A network-based data integration approach to support drug repurposing and multi-Target therapies in triple negative breast cancer",
abstract = "The integration of data and knowledge from heterogeneous sources can be a key success factor in drug design, drug repurposing and multi-Target therapies. In this context, biological networks provide a useful instrument to highlight the relationships and to model the phenomena underlying therapeutic action in cancer. In our work, we applied network-based modeling within a novel bioinformatics pipeline to identify promisingmulti-Target drugs. Given a certain tumor type/subtype, we derive a disease-specific Protein-Protein Interaction (PPI) network by combining different data-bases and knowledge repositories. Next, the application of suitable graph-based algorithms allows selecting a set of potentially interesting combinations of drug targets. A list of drug candidates is then extracted by applying a recent data fusion approach based on matrix tri-factorization.Available knowledge about selected drugs mechanisms of action is finally exploited to identify the most promising candidates for planning in vitro studies.We applied this approach to the case of Triple Negative Breast Cancer (TNBC), a subtype of breast cancer whose biology is poorly understood and that lacks of specific molecular targets. Our {"}in-silico{"} findings have been confirmedby a number of in vitro experiments, whose results demonstrated the ability of the method to select candidates for drug repurposing.",
author = "Francesca Vitali and Cohen, {Laurie D.} and Andrea Demartini and Angela Amato and Vincenzo Eterno and Alberto Zambelli and Riccardo Bellazzi",
year = "2016",
month = "9",
day = "1",
doi = "10.1371/journal.pone.0162407",
language = "English",
volume = "11",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "9",

}

TY - JOUR

T1 - A network-based data integration approach to support drug repurposing and multi-Target therapies in triple negative breast cancer

AU - Vitali, Francesca

AU - Cohen, Laurie D.

AU - Demartini, Andrea

AU - Amato, Angela

AU - Eterno, Vincenzo

AU - Zambelli, Alberto

AU - Bellazzi, Riccardo

PY - 2016/9/1

Y1 - 2016/9/1

N2 - The integration of data and knowledge from heterogeneous sources can be a key success factor in drug design, drug repurposing and multi-Target therapies. In this context, biological networks provide a useful instrument to highlight the relationships and to model the phenomena underlying therapeutic action in cancer. In our work, we applied network-based modeling within a novel bioinformatics pipeline to identify promisingmulti-Target drugs. Given a certain tumor type/subtype, we derive a disease-specific Protein-Protein Interaction (PPI) network by combining different data-bases and knowledge repositories. Next, the application of suitable graph-based algorithms allows selecting a set of potentially interesting combinations of drug targets. A list of drug candidates is then extracted by applying a recent data fusion approach based on matrix tri-factorization.Available knowledge about selected drugs mechanisms of action is finally exploited to identify the most promising candidates for planning in vitro studies.We applied this approach to the case of Triple Negative Breast Cancer (TNBC), a subtype of breast cancer whose biology is poorly understood and that lacks of specific molecular targets. Our "in-silico" findings have been confirmedby a number of in vitro experiments, whose results demonstrated the ability of the method to select candidates for drug repurposing.

AB - The integration of data and knowledge from heterogeneous sources can be a key success factor in drug design, drug repurposing and multi-Target therapies. In this context, biological networks provide a useful instrument to highlight the relationships and to model the phenomena underlying therapeutic action in cancer. In our work, we applied network-based modeling within a novel bioinformatics pipeline to identify promisingmulti-Target drugs. Given a certain tumor type/subtype, we derive a disease-specific Protein-Protein Interaction (PPI) network by combining different data-bases and knowledge repositories. Next, the application of suitable graph-based algorithms allows selecting a set of potentially interesting combinations of drug targets. A list of drug candidates is then extracted by applying a recent data fusion approach based on matrix tri-factorization.Available knowledge about selected drugs mechanisms of action is finally exploited to identify the most promising candidates for planning in vitro studies.We applied this approach to the case of Triple Negative Breast Cancer (TNBC), a subtype of breast cancer whose biology is poorly understood and that lacks of specific molecular targets. Our "in-silico" findings have been confirmedby a number of in vitro experiments, whose results demonstrated the ability of the method to select candidates for drug repurposing.

UR - http://www.scopus.com/inward/record.url?scp=84992413607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84992413607&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0162407

DO - 10.1371/journal.pone.0162407

M3 - Article

AN - SCOPUS:84992413607

VL - 11

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 9

M1 - e0162407

ER -